The efficiency and safety of dexamethasone for pain control in total joint arthroplasty: A meta-analysis of randomized controlled trials

Jian Meng, Lin Li, Jian Meng, Lin Li

Abstract

Background: This meta-analysis aimed to evaluate the efficiency and safety of dexamethasone administration in total knee and hip arthroplasties.

Methods: Two researchers search the relevant studies independently including Embase (1980-017.04), PubMed (1966-017.04), ScienceDirect (1985-017.04), Web of Science (1950-2017.03), and Cochrane Library for potential relevant studies. After testing for heterogeneity between studies, data were aggregated for random-effects models when necessary. The results of dichotomous outcomes were expressed as risk difference (RD) with a 95% confidence intervals (CIs). For continuous various outcomes, mean difference (MD) or standard mean difference (SMD) with a 95% confidence intervals (CIs) was applied for assessment. Meta-analysis was performed using Stata 11.0 software.

Results: Four randomized controlled trials (RCTs) including 361 patients met the inclusion criteria. The present meta-analysis indicated that there were significant differences between groups in terms of visual analogue scale (VAS) score at 12 hours (SMD = -0.579, 95% CI: -0.780 to -0.357, P = .000), 24 hours (SMD = -0.820, 95% CI: -1.036 to -0.604, P = .000), and 48 hours (SMD = -0.661, 95% CI: -1.149 to -0.172, P = .008). Dexamethasone was associated with a lower opioid consumption at 12 hours (SMD = -0.245, 95% CI: -0.465 to -0.025, P = .029), 24 hours (SMD = -0.285, 95% CI: -0.505 to -0.064, P = .011), and 48 hours (SMD = -0.989, 95% CI: -1.710 to -0.267, P = .007).

Conclusion: Dexamethasone could significantly reduce postoperative pain scores and opioid consumption within the 1st 48 hours following total joint arthroplasty (TJA). The overall evidence quality was moderate to low, further high-quality RCTs are needed to identify the optimal dose of dexamethasone for reducing pain after TJA.

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Search results and the selection procedure.
Figure 2
Figure 2
Forest plot diagram showing VAS scores at 12 hours following TJA. TJA = total joint arthroplasty, VAS = visual analogue scale.
Figure 3
Figure 3
Forest plot diagram showing VAS scores at 24 hours following TJA. TJA = total joint arthroplasty, VAS = visual analogue scale.
Figure 4
Figure 4
Forest plot diagram showing VAS scores at 48 hours following TJA. TJA = total joint arthroplasty, VAS = visual analogue scale.
Figure 5
Figure 5
Forest plot diagram showing opioid consumption at 12 hours following total joint arthroplasty (TJA).
Figure 6
Figure 6
Forest plot diagram showing opioid consumption at 24 hours following total joint arthroplasty (TJA).
Figure 7
Figure 7
Forest plot diagram showing opioid consumption at 48 hours following total joint arthroplasty (TJA).
Figure 8
Figure 8
Forest plot diagram showing length of stay following total joint arthroplasty (TJA).
Figure 9
Figure 9
Forest plot diagram showing incidence of nausea following total joint arthroplasty (TJA).
Figure 10
Figure 10
Forest plot diagram showing incidence of vomiting following total joint arthroplasty (TJA).

References

    1. Salerno A, Hermann R. Efficacy and safety of steroid use for postoperative pain relief. Update and review of the medical literature. J Bone Joint Surg Am 2006;88:1361–72.
    1. Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003;97:62–71. table of contents.
    1. DiIorio TM, Sharkey PF, Hewitt AM, et al. Antiemesis after total joint arthroplasty: does a single preoperative dose of aprepitant reduce nausea and vomiting? Clin Orthop Relat Res 2010;468:2405–9.
    1. Thorsell M, Holst P, Hyldahl HC, et al. Pain control after total knee arthroplasty: a prospective study comparing local infiltration anesthesia and epidural anesthesia. Orthopedics 2010;33:75–80.
    1. Kuchalik J, Granath B, Ljunggren A, et al. Postoperative pain relief after total hip arthroplasty: a randomized, double-blind comparison between intrathecal morphine and local infiltration analgesia. Br J Anaesth 2013;111:793–9.
    1. Chan MH, Chen WH, Tung YW, et al. Single-injection femoral nerve block lacks preemptive effect on postoperative pain and morphine consumption in total knee arthroplasty. Acta Anaesthesiol Taiwan 2012;50:54–8.
    1. Bahammam MA, Kayal RA, Alasmari DS, et al. Comparison between dexamethasone and ibuprofen for postoperative pain prevention and control after surgical implant placement: a double-masked, parallel-group, placebo-controlled randomized clinical trial. J Periodontol 2017;88:69–77.
    1. Naja Z, Kanawati S, Al Khatib R, et al. The effect of IV dexamethasone versus local anesthetic infiltration technique in postoperative nausea and vomiting after tonsillectomy in children: a randomized double-blind clinical trial. Int J Pediatr Otorhinolaryngol 2017;92:21–6.
    1. Abe M, Hirashima Y, Kasamatsu Y, et al. Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial. Support Care Cancer 2016;24:675–82.
    1. Ikeuchi M, Kamimoto Y, Izumi M, et al. Effects of dexamethasone on local infiltration analgesia in total knee arthroplasty: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 2014;22:1638–43.
    1. Sherif AA, Elsersy HE. Dexamethasone as adjuvant for femoral nerve block following knee arthroplasty: a randomized, controlled study. Acta Anaesthesiol Scand 2016;60:977–87.
    1. Kardash KJ, Sarrazin F, Tessler MJ, et al. Single-dose dexamethasone reduces dynamic pain after total hip arthroplasty. Anesth Analg 2008;106:1253–7.
    1. Backes JR, Bentley JC, Politi JR, et al. Dexamethasone reduces length of hospitalization and improves postoperative pain and nausea after total joint arthroplasty: a prospective, randomized controlled trial. J Arthroplasty 2013;28(8 Suppl):11–7.
    1. Kurosaka K, Tsukada S, Seino D, et al. Local infiltration analgesia versus continuous femoral nerve block in pain relief after total knee arthroplasty: a randomized controlled trial. J Arthroplasty 2016;31:913–7.
    1. Ishida K, Shibanuma N, Matsumoto T, et al. Periarticular multimodal drug injection improves post-operative pain and functional recovery after total knee arthroplasty. J Orthop Sci 2016;21:178–83.
    1. D’Ambrosio A, Spadaro S, Natale C, et al. Continuous spinal analgesia with levobupivacaine for postoperative pain management: Comparison of 0.125% versus 0.0625% in elective total knee and hip replacement: a double-blind randomized study. J Anaesthesiol Clin Pharmacol 2015;31:478–84.
    1. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000;90:186–94.
    1. Sean VW, Chin PL, Chia SL, et al. Single-dose periarticular steroid infiltration for pain management in total knee arthroplasty: a prospective, double-blind, randomised controlled trial. Singapore Med J 2011;52:19–23.
    1. Kim YJ, Lee GY, Kim DY, et al. Dexamathasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean J Anesthesiol 2012;62:130–4.
    1. Christensen CP, Jacobs CA, Jennings HR. Effect of periarticular corticosteroid injections during total knee arthroplasty. A double-blind randomized trial. J Bone Joint Surg Am 2009;91:2550–5.
    1. Ma J, Zhang W, Yao S. Liposomal bupivacaine infiltration versus femoral nerve block for pain control in total knee arthroplasty: a systematic review and meta-analysis. Int J Surg 2016;36(Pt A):44–55.
    1. Tammachote N, Kanitnate S, Manuwong S, et al. Is pain after TKA better with periarticular injection or intrathecal morphine? Clin Orthop Relat Res 2013;471:1992–9.
    1. Wheeler M, Oderda GM, Ashburn MA, et al. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain 2002;3:159–80.
    1. Sauerland S, Nagelschmidt M, Mallmann P, et al. Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review. Drug Saf 2000;23:449–61.

Source: PubMed

3
Iratkozz fel